Does blood miRNA-29b have value in the diagnosis of acute myocardial infarction and the evaluation of postinfarction cardiac function?
Blood miRNA-29b may serve as a useful biomarker for diagnosing acute myocardial infarction and assessing subsequent cardiac function impairment.
Blood miRNA-29b is lower in patients with AMI, particularly in those with impaired cardiac function. miRNA-29b demonstrates potential value in the diagnosis of AMI and the assessment of postinfarction cardiac function.
Wang et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: